US4785119A - 3-aminopyrrolidine compound and process for preparation thereof - Google Patents

3-aminopyrrolidine compound and process for preparation thereof Download PDF

Info

Publication number
US4785119A
US4785119A US06916936 US91693686A US4785119A US 4785119 A US4785119 A US 4785119A US 06916936 US06916936 US 06916936 US 91693686 A US91693686 A US 91693686A US 4785119 A US4785119 A US 4785119A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
aminopyrrolidine
phenyl
ml
sub
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06916936
Inventor
Kou Hojo
Anji Sakamoto
Masumi Tsutsumi
Tamotsu Yamada
Kazuhiko Nakazono
Kazuya Ishimori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Kasei Kogyo Co Ltd
Original Assignee
Tokyo Kasei Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Abstract

Disclosed is a novel compound of 3-aminopyrrolidine having the formula (I): ##STR1## in which R1 is hydrogen, an alkyl, an aralkyl or an aryl.

Description

This invention relates to 3-aminopyrrolidines and to a process for preparing the same. More particularly, it relates to 3-aminopyrrolidines having the general formula: ##STR2## wherein R1 is a member selected from the group consisting of a hydrogen atom, and alkyl, aralkyl, and aryl radicals.

One object of the present invention is to provide novel parent 3-aminopyrrolidine and N,N'-disubstituted 3-aminopyrrolidines, and salts thereof, which are useful as starting materials, and as building blocks for construction of useful products in chemical, pharmaceutical, and agricultural industries. In particular, some 3-aminopyrrolidine derivatives have been used recently in making particular antibacterial agents, which showed striking activities (J. Matsumoto et al., J. Med. Chem., 27, 1543(1984)).

The another object of the present invention is to provide a novel and general process for the production of parent 3-aminopyrrolidine and N,N'-disubstituted 3-aminopyrrolidines, and salts thereof.

STATEMENT OF PRIOR ARTS

C. D. Lunsford and coworkers reported in 1967˜1968 the synthesis of some N,N'-substituted 3-aminopyrrolidines by the reaction of primary or secondary amines with 1-substituted 3-chloropyrrolidines or 1-substituted 3-tosyloxypyrrolidines, which had been prepared from 1-substituted 3-pyrrolidinol. These N,N'-substituted 3-aminopyrrolidines were used in making a number of aminoalkylindols, which showed a significant central nervous system depressant activity [C. D. Lunsford et al., J. Med. Chem., 10, 1015(1967); ibid., 11, 1034(1968), U.S. Pat. No. 2,830,997].

SUMMARY OF THE INVENTION

The invention provides a 3-aminopyrrolidine compound and a process for preparation thereof. In particular it provides a compound of 3-aminopyrrolidine having the formula (I): ##STR3## in which R1 is hydrogen, an alkyl, an aralkyl or an aryl.

The present invention compound includes one in which R1 in the formula (I) is hydrogen and another compound in which R1 in the formula is an alkyl having 1 to 20 carbon atoms, preferably 1 to 3 carbon atoms, an aralkyl having 1 or 2 carbon atoms in the alkylene and 1 or 2 phenyl rings or a phenyl which may have a substituent such as methyl, methoxy, a halogen and nitro. In the latter group, R1 preferably is methyl, ethyl, benzyl or phenyl.

The present invention provides a process for preparing a compound as defined above which comprises reacting 1,2,4-trisubstituted butane having the formula (II):

XCH.sub.2 CHYCH.sub.2 CH.sub.2 Z                           (II)

in which X, Y and Z each are a halogen or OR, R being an alkylsulfonyl or an arylsulfonyl, with a primary amine having the formula (III): R1 NH2 in which R1 is defined above. It is preferably that R is an alkylsulfonyl having 1 to 6 carbon atoms in the alkyl or an arylsulfonyl such as phenylsulfonyl which may have a substituent on the phenyl portion such as methyl, methoxy, a halogen and nitro.

The above shown process provides an intermediate compound having the formula (I) in which R1 is an aralkyl or a salt thereof with a protonic acid. The intermediate compound may be catalytically hydrogenated to produce 3-aminopyrrolidine. The intermediate compound preferably includes one in which R1 has the formula (IV): R2 R3 CH in which R2 is phenyl or a substituted phenyl and R3 is hydrogen, an alkyl or phenyl. The phenyl for R2 may be substituted by methyl, methoxy, a halogen or nitro.

According to the present invention, novel 3-aminopyrrolidines represented by the general formula: ##STR4## can be obtained in one step by the reaction of 1,2,4-trisubstituted butanes, represented by the general formula:

XCH.sub.2 CHYCH.sub.2 CH.sub.2 Z

wherein X, Y, and Z represent a halogen atom or OR group in which R is either an alkane sulfonyl or aromatic sulfonyl radical, with primary amines represented by the general formula:

R.sup.1 NH.sub.2

wherein R1 is a member selected from the group consisting of a hydrogen atom, an alkyl radical having 1 to 20 carbon atoms, an aralkyl radical comprising benzyl, α-phenethyl, or diphenylmethyl radical with or without substituents on the aliphatic carbon and/or on the benzene ring, and a phenyl radical with or without substituents on the benzene ring.

A number of N,N'-disubstituted 3-aminopyrrolidines can be prepared by the method of the present invention. As examples of such compounds, one can mention parent 3-aminopyrrolidine, N,N'-dimethyl-3-aminopyrrolidine, N,N'-diethyl-3-aminopyrrolidine, N,N'-dibenzyl-3-aminopyrrolidine, and N,N'-diphenyl-3-amino-pyrrolidine.

Alternatively, parent 3-aminopyrrolidine is also prepared according to the present invention by catalytic hydrogenation of N,N'-disubstituted-3-aminopyrrolidines represented by the general formula: ##STR5## which are prepared by the reaction of the 1,2,4-trisubstituted butanes defined above, with primary amines having the general formula:

R.sup.2 (R.sup.3)CHNH.sub.2,

wherein R2 is a phenyl or substituted phenyl radical, and R3 is a member selected from the group consisting of a hydrogen atom, an alkyl radical having 1 to 4 carbon atoms, and phenyl or substituted phenyl radical. As examples of such N,N'-disubstituted 3-aminopyrrolidines, one can mention N,N'-dibenzyl-3-aminopyrrolidine, N,N'-bis(1-phenethyl)-3-aminopyrrolidine, and N,N'-bis(diphenylmethyl)-3-aminopyrrolidine.

The process of the present invention is explained in details. As 1,2,4-trisubstituted butanes that can be used in the process of the present invention, following compounds can be mentioned for instance; 1,2,4-trichlorobutane, 1,2,4-tribromobutane, 1,4-dibromo-2-methanesulfonoxybutane, 1,2-dibromo-4-chlorobutane, 1,2,4-tris(methanesulfonoxy)butane, 1,2,4-tris(p-toluenesulfonoxy)butane, and 3,4-dibromo-1-methanesulfonoxybutane. These 1,2,4-trisubstituted butanes can be readily prepared starting from comercially available compounds like 1,2,4-butanetriol, 3-butene-1-ol, 4-chloro-1-butene, and 4-bromo-1-butene by conventional methods in the art.

According to the present invention, 3-aminopyrrolidines that have two identical substituents on nitrogen atoms at 1- and 3-positions, can be prepared by simply treating 1,2,4-trisubstituted butanes with primary amines. This type of reaction is so simple that one can perform under a variety of reaction conditions, in the presence or absence of another base and solvent. In any case, it is preferable to employ sufficient amounts of primary amines (more than 3 equivalents), and reaction temperature of 40° to 150° C.

As the base, ordinary alkalis like metal hydroxides, metal carbonates, and metal alkoxides are preferable; a primary amine that is to be introduced into a pyrrolidine ring system can be employed as well.

The reaction of the present invention can be performed in a homogeneous system using ordinary solvents like water, ethanol, isopropyl alcohol, benzene, and toluene. The reaction can also be carried out in a heterogeneous two phase system using organic solvents and aqueous alkalis.

Parent 3-aminopyrrolidine can be prepared according to the present invention by treatment of trisubstituted butanes with ammonia, preferably being performed in an autoclave. The reaction can be carried out in organic solvents, in water, or in liquid ammonia. Use of large excess of ammonia is essential; preferably 20˜80 times moles of ammonia to that of trisubstituted butanes is used. The reaction temperature of 20°-120° C., and the reaction period of 1˜20 hr are usually employed depending on the reactivities of trisubstituted butanes.

Parent 3-aminopyrrolidine or its protonic acid salts can be conveniently prepared by catalytic hydrogenation of the corresponding N,N'-disubstituted 3-aminopyrrolidines or its protonic acid salts, which have two identical substituents that can be removed by reduction. Catalytic hydrogenations of N,N'-substituted 3-aminopyrrolidines is usually carried out in an autoclave in ordinary solvents like water, methanol, ethanol, isopropyl alcohol, tetrahydrofuran, dioxane, dimethoxyethane, and acetic acid. The reduction proceeds in a single or mixed solvent system. Catalysts like Pd--C, Pd--BaSO4, PdO, and PtO2 are preferable and these can be used as much as 5 to 20% weight of the starting material employed. Reductions are usually carried out at temperature 20° to 150° C. under the hydrogen pressure of 1 to 30 kg/cm2, and are completed in 2 to 12 hours.

In general, catalytic hydrogenations of protonic acid salts of substituted 3-aminopyrrolidines proceed under milder conditions and give better yields than the case in which free N-substituted 3-aminopyrrolidines are employed.

Therefore, when needed, it is advantageous to carry out the reduction of N-substituted 3-aminopyrrolidines in the form of its protonic acid salts.

The process of the present invention is described in more detail with reference to the following examples, which are however to be construed for the purpose of illustration and not for the limitation.

EXAMPLE 1 3-Aminopyrrolidine

Liquid ammonia (370 g) is introduced at room temperature into an autoclave which contained 1,2,4-tribromobutane (88 g, bp 99.5° C./5.5 mmHg). The mixture is stirred for 20 hr at 45°˜50° C. under the pressure of 70 kg/cm2. After completion of reaction, excess ammonia is evaporated, and water (300 ml) and then sodium hydroxide (72 g) are added to the residue. 3-Aminopyrrolidine is co-distilled with water. To the distillate is added concd hydrochloric acid (50 ml) and the solution is concentrated to dryness to give crude 3-aminopyrrolidine dihydrochloride (18.9 g, 39.8% ). This is added to methanol (80 ml) solution of sodium methoxide (13.2 g), and precipitated sodium chloride is filtered. Distillation of the filtrate under the atmosphere of nitrogen gave 3-aminopyrrolidine 8.1 g (31.7%) which boiled at 159°˜160° C.

nD 20 1.4897. SG20 20 0.9910.

NMR (CDCl3) δ=3.30˜3.70 (m, 2H), 2.43˜3.23 (m, 4H), 1.13˜2.26 (m, 2H), 1.50 (s, 3H).

IR (neat) 3250, 1600, 870 cm-1 (--NH2).

Solubility

Freely soluble in water, ethanol, diethyl ether, tetrahydrofuran, dioxane, acetonitrile, chloroform, carbon tetrachloride, benzene. Soluble in hexane.

Derivatives 3-Aminopyrrolidine dihydrochloride

NMR (DMSO-d6) δ=8.33˜10.10 (s, broad, 5H), 3.66˜4.23 (m, 1H), 2.93˜3.66 (m, 4H), 1.93˜2.50 (m, 2H).

IR (KBr) 3200˜2800, 1590˜1550 cm-1 (NH3 +).

Chlorine content (C4 H12 N2 Cl2): Calcd. (%) 44.58; Found (%) 43.35.

N,N'-Diacetyl-3-aminopyrrolidine

NMR (CDCl3) δ=7.00˜7.40 (s, broad, 1H), 4.17˜4.73 (m, 1H), 3.13˜3.90 (m, 4H), 1.77˜2.47 (m, 8H).

IR (neat) 3400˜3250, 1670˜1620, 1550 cm-1.

EXAMPLE 2 N,N'-Dimethyl-3-aminopyrrolidine

1,2,4-Tris(methanesulfonoxy)butane (170.2 g, mp 63.5°˜64.5° C.) is added to 40 (w/w)% aqueous solution of methylamine (863 ml). The mixture is gradually heated with stirring to 84°˜94° C. and kept at this temperature for 2.5 hr.

The reaction mixture is concentrated, and sodium hydroxide (200 g) in water (400 ml) added to the residue. The mixture is shaken with benzene (2×300 ml), and combined benzene layers are dried over magnesium sulfate, and concentrated at an atmospheric pressure. The crude material (50.7 g, 88.8%) was purified by distillation through a Vigreux column (20 cm) under a nitrogen atmosphere to give N,N'-dimethyl-3-aminopyrrolidine (26.8 g, 46.9%), which boiled at 148°˜149° C.

nD 20 1.4562. SG20 20 0.8824.

NMR (CDCl3) δ=3.07˜3.40 (m, 1H), 2.40 (s, 3H), 2.37 (s, 3H), 1.33˜2.83 (m, 7H).

IR (neat) 3250 cm-1.

EXAMPLE 3 N,N'-Diethyl-3-aminopyrrolidine

1,2,4-Tribromobutane (294.9 g, bp 99.5° C./5.5 mmHg) is added to 70 (w/w)% aqueous solution of ethylamine (1600 ml).

The mixture is gradually heated with stirring to 83°˜85° C. and kept at this temperature for 1.5 hr. The reaction mixture is concentrated, and sodium hydroxide (400 g) in water (800 ml) added to the residue. The mixture is shaken with benzene (2×300 ml), and combined benzene layers are dried over magnesium sulfate. It is concentrated at an atmospheric pressure and crude N,N'-diethyl-3-aminopyrrolidine (114.1 g, 80.2%) is distilled under a nitrogen atmosphere.

Yield 77.5 g (54.5%). bp 178°-182° C.

This product is further purified in the form of its hydrochloric acid salt as follows: the product is added dropwise to the stirred solution of hydrogen chloride (41.7 g) in ethanol (180 ml). N,N'-Diethyl-3-aminopyrrolidine dihydrochloride precipitated, which is collected and recrystalized from ethanol (150 ml). White crystalline (88.0 g, 77.1%, mp 170°˜172° C., chlorine content: found 32.88%, calcd. 32.96%) is obtained, which is then added portionwise to sodium methoxide (44.1 g) in methanol (200 ml) and heated to reflux for 30 min. Sodium chloride is removed by filtration, and a filtrate concentrated at an atmospheric pressure. Distillation of a residual liquid under a nitrogen atmosphere gave N,N'-diethyl-3-aminopyrrolidine (41.8 g, 71.8%) which boiled at 180°-182° C.

nD 20 1.4553.

NMR (CDCl3) δ=3.10˜3.46 (m, 1H), 1.30˜2.90 (m, 11H), 1.10 (t, J=6 Hz, 6H).

IR (neat) 3200 cm-1.

EXAMPLE 4 N,N'-Diphenyl-3-aminopyrrolidine

To a mixture of aniline (27.3 ml) and sodium hydroxide (6 g) in water (15 ml), is added with stirring 1,2,4-tribromobutane (14.7 g, bp 99.5° C./5.5 mmHg). The mixture is gradually heated to 100° C. and maintained at this temperature for 3 hr. and then cooled. Benzene (30 ml) and water (10 ml) are added, and the mixture is shaken. Organic layer is separated, washed with water, dried over sodium sulfate, and concentrated. Excess aniline is removed by distillation under reduced pressure (36°˜39° C./1 mmHg). The residual liquid (10.3 g, 86.4%) is distilled to give N,N'-diphenyl-3-aminopyrrolidine (8.4 g, 70.7%) which boiled at 193°˜194° C./1 mmHg, and solidified at room temperature. The solid melted at 68°˜70° C. and also showed melting point of 68°˜70° C. after being recrystallized from ethanol.

NMR (CDCl3) δ=6.43˜7.47 (m, 10H), 4.00˜4.37 (m, 1H), 3.03˜3.80 (m, 5H), 1.67˜2.57 (m, 2H).

IR (neat) 3350, 1595 cm-1.

EXAMPLE 5 N,N'-Dibenzyl-3-aminopyrrolidine and 3-aminopyrrolidine

(a). To a mixture of benzylamine (192.9 g) and sodium hydroxide (36 g) in water (36 ml) is added with stirring 1,2,4-tribromobutane (88.4 g, bp 99.5° C./5.5 mmHg) in 5 mim. Exothermic reaction took place gradually, and temperature of the reaction mixture reached around 105°˜110° C. After being maintained at this temperature for 2 hr, it is cooled to room temperature. Water (100 ml) and benzene (100 ml) are added, and the mixture is shaken. Organic layer was separated, washed with water, and concentrated. Removal of excess benzylamine by distillation under reduced pressure gave crude N,N'-dibenzyl-3-aminopyrrolidine (68.9 g, 86.2%), which is distilled under reduced pressure to give N,N'-dibenzyl-3-aminopyrrolidine. Yield 57.6 g (72.1%), bp 185°˜189° C./2 mmHg.

nD 20 1.5691. d20 20 1.0454.

NMR (CDCl3) δ=7.43 (s, 10H), 3.80 (s, 2H), 3.68 (s, 2H), 1.20˜3.57 (m, 8H).

IR (neat) 3300, 1140 cm-1 (--NH--).

Elemental analysis (C18 H22 N2): Calcd (%): C, 81.16; H, 8.32; N, 10.52. Found (%): C, 80.65; H, 8.48; N, 10.50.

In an autoclave, N,N'-dibenzyl-3-aminopyrrolidine (80 g) dissolved in methanol (300 ml) is stirred for 12 hr at 115° C. over 5% Pd--C catalyst (4 g) under the pressure of hydrogen (20 kg/cm2). After completion of reaction, catalyst is removed by filtration, and the filtrate was carefully concentrated at atmospheric pressure. Distillation of the residual liquid under nitrogen atomosphere gave 3-aminopyrrolidine (16.0 g 61.9%), which boiled at 159°˜160° C.

nD 20 1.4897, SG20 20 0.9910.

NMR (CDCl3) δ=3.30˜3.70 (m, 1H), 2.43˜3.23 (m, 4H), 1.13˜2.26 (m, 2H), 1.50 (s, 3H).

IR (neat) 3250, 1600, 870 cm-1 (--NH2).

Derivatives 3-Aminopyrrolidine dihydrochloride

NMR (DMSO-d6) δ=8.33˜10.10 (s, broad, 5H), 3.66˜4.23 (m, 1H), 2.93˜3.66 (m, 4H), 1.93˜2.50 (m, 2H).

IR (KBr) 3200˜2800, 1590˜1550 cm-1 (NH3 +).

Elemental analysis (C4 H12 N2 Cl2): Calcd. (%): C, 30.21; H, 7.60; N, 17.61. Found (%): C, 29.93; H, 7.63; N, 17.45.

Chlorine content Calcd (%): 44.58 Found (%): 43.74

(b). N,N'-Dibenzyl-3-aminopyrrolidine is prepared by the reaction of various 1,2,4-trisubstituted butanes with benzylamine under similar conditions as those described in EXAMPLE 5a, and is subsequently hydrogenated to 3-aminopyrrolidine. Results are summarized in a following table.

              TABLE 1______________________________________N,N'--Dibenzyl-3-aminopyrrolidine and 3-amino-pyrrolidine from various 1,2,4-trisubstituted butanes       N,N'--Dibenzyl-3-       aminopyrrolidine                      3-AminopyrrolidineStarting Material       yield (%)      yield (%)______________________________________3.4-Dibromo-1-       63.7           62.0methanesulfonoxy-butane(bp 137˜139/1 mmHg)1,4-Dibromo-2-       64.0           62.0methanesulfonoxy-butane(viscous liquid)1,2,4-Tris(p-toluene-       30.7           62.5sulfonoxy)butane(mp 91.0˜91.7° C.)1,2-Dibromo-4-       26.8           62.0chlorobutane(bp 87.5˜88.5° C./8 mmHg)1,2,4-Tris(methane-       74.3           62.5sulfonoxy)butane(mp 63.5˜64.5° C.)______________________________________

(c). A mixture of 1,2,4-trichlorobutane (161 g, bp 61.5°˜62.0° C./9 mmHg) and benzylamine (1072 g) is gradually heated to 140°˜150° C. and stirred for 19 hr at this temperature. After being cooled in ice, benzene (500 ml) is added to the mixture, and precipitates (benzylamine hydrochloride) are filtered. The filtrate is concentrated, and excess benzylamine is removed by distillation under reduced pressure. Distillation of residual liquid gave N,N'-benzyl-3-aminopyrrolidine. Yield 152 g (57.2%), bp 180°˜182° C./3 mmHg.

This is hydrogenated at 115° C. over 5% Pd--C (15 g) in methanol (200 ml) under the hydrogen pressure of 20 kg/cm2 for 12 hr. Similar work-up as those described in EXAMPLE 5a gave 3-aminopyrrolidine (30.7 g, 62.5%), which boiled at 159°˜160° C.

EXAMPLE 6 N,N'-Bis(1-phenylethyl)-3-aminopyrrolidine and 3-aminopyrrolidine

To a mixture of 1-phenylethylamine (363.5 g) and sodium hydroxide (60 g) in water (120 ml) is added with stirring 1,2,4-tris(methanesulfonoxy)butane (170.2 g, mp 63.5°˜64.5° C.).

The mixture is gradually heated to 110° C. and maintained at this temperature for 3 hr, and then cooled to room temperature. To this are added water (50 ml) and benzene (400 ml), and the mixture is shaken. Organic layer was separated, washed with water, and concentrated. Excess 1-phenylethylamine is removed by distillation under reduced pressure. Distillation of the residual liquid gave N,N'-bis(1-phenylethyl)-3-aminopyrrolidine (87.4 g, 59.3%) which boiled at 175°˜177° C./2 mmHg.

nD 20 1.5552. SG20 20 1.0201.

NMR (CDCl3) δ=7.30 (s, 10H), 3.53˜3.93 (m, 1H), 2.87˜3.40 (m, 2H), 1.47˜2.83 (m, 7H), 1.40 (d, 3H), 1.28 (d, 3H).

IR (neat) 1150 cm-1.

Elemental analysis (C20 H26 N2): Calcd (%): C, 81.59; H, 8.90; N, 9.51. Found (%): C, 81.62; H, 8.48; N, 9.52.

In an autoclave, N,N'-bis(1-phenylethyl)-3-aminopyrrolidine (73.6 g) is hydrogenated at 120° C. over 5% Pd--C (15 g) in methanol (200 ml) under the hydrogen pressure of 18 kg/cm2 for 20 hr. After completion of reaction, catalyst is removed by filtration, and the filtrate is carefully concentrated at an atmospheric pressure. Distillation of the residual liquid under nitrogen atmosphere gave 3-aminopyrrolidine (8.8 g, 36.8%), which boiled at 159°˜160° C.

Ethylbenzene (bp 136° C.) is readily separated by distillation. NMR and IR spectra of this compound are identical with those obtained in EXAMPLE 5a.

EXAMPLE 7 N,N'-Bis(diphenylmethyl)-3-aminopyrrolidine and 3-aminopyrrolidine

To a mixture of benzhydrylamine (439.8 g) and sodium hydroxide (48 g) in water (100 ml) is added with stirring 1,2,4-tris(methanesulfonoxy)butane (136.1 g, mp 63.5°˜64.5° C.).

The mixture is gradually heated to 110° C. and maintained at this temperature for 5 hr, and then cooled to room temperature. To this are added water (50 ml) and benzene (400 ml), and the mixture is shaken. Organic layer was separated, washed with water, and concentrated. Excess benzhydrylamine is removed by distillation under reduced pressure. The residue is dissolved in hot isopropyl alcohol (400 ml), from which N,N'-bis(diphenylmethyl)-3-aminopyrrolidine (73.6 g, 43.9%) crystallized. This is recrystallized from isopropyl alcohol (200 ml). Yield 57.9 g (34.5%). mp. 106°˜107° C.

NMR (CDCl3) δ=6.87˜7.60 (m, 20H), 4.80 (s, 1H), 4.17 (s, 1H), 300˜3.43 (m, 1H), 1.30˜2/83 (m, 7H).

IR (KBr) 3350 cm-1.

Elemental Analysis (C30 H30 N2): Calcd. (%) C, 86.06; H, 7.22; N, 6.69. Found (%) C, 86.33; H, 7.34; N, 6.82.

In an autoclave, N,N'-bis(diphenylmethyl)-3-aminopyrrolidine (50.0 g) is hydrogenated at 105° C. over 5% Pd--C (10 g) in tetrahydrofuran (200 ml) under the hydrogen pressure of 16 kg/cm2 for 3 hr. After completion of reaction, catalyst is removed by filtration, and the filtrate was carefully concentrated. Distillation of the residual liquid under reduced pressure (11 mmHg at 40°˜60° C.), gave fractions enriched in 3-aminopyrrolidine, from which pure 3-aminopyrrolidine (bp 159°˜160° C., 6.0 g, 58.4%) is obtained by distillation at an atmospheric pressure. Diphenylmethane (bp 264.5° C./760 mmHg) is readily separated.

EXAMPLE 8 N,N'-Dibenzyl-3-aminopyrrolidine dihydrochloride and 3-aminopyrrolidine dihydrochloride

N,N'-Dibenzyl-3-aminopyrrolidine (150 g, bp 185°˜189° C./2 mmHg, prepared according to the procedure described in EXAMPLE 5a) is added dropwise with stirring and ice cooling, to ethanol (600 ml) solution of hydrogen chloride (42 g), and the mixture is stirred for 2 hr. N,N'-Dibenzyl-3-aminopyrrolidine dihydrochloride precipitated, which is collected by suction filtration, and recrystallized from ethanol (880 ml).

Yield 184.8 g (96.8%), mp 235.2°˜236.8° C. (dec.).

Chlorine Content (C18 H24 N2 Cl2): Calcd (%) 20.90. Found (%) 20.86.

In an autoclave, N,N'-dibenzyl-3-aminopyrrolidine dihydrochloride (85 g) is hydrogenated at 35° C. over 5% Pd--C (8.5 g) in a mixed solvent of methanol (160 ml) and water (40 ml) under the hydrogen pressure of 10 kg/cm2 for 5 hr. After completion of reaction, catalyst is removed by filtration, and the filtrate is concentrated. Ethanol (100 ml) is added to the residue, and white crystalline solid of 3-aminopyrrolidine dihydrochloride is collected by suction filtration. Yield 35.4 g (88.9%).

NMR (DMSO-d6) δ=8.33˜10.10 (s, broad, 5H), 3.66˜4.23 (m, 1H), 2.93˜3.66 (m, 4H), 1.93˜2.50 (m, 2H).

IR (KBr) 3200˜2800, 1590˜1550 cm-1 (--NH3 +).

Elemental analysis (C4 H12 N2 Cl2): Calcd (%): C, 30.21; H, 7.60; N, 17.61. Found (%): C, 29.93; H, 7.63; N, 17.45.

Chlorine content: Calcd (%): 44.58. Found (%): 43.74.

Claims (5)

What is claimed is:
1. A process for preparing a compound of 3-aminopyrrolidine having the formula: ##STR6## in which R1 is hydrogen, which comprises reacting 1,2,4-trisubstituted butane having the formula:
XCH.sub.2 CHYCH.sub.2 CH.sub.2 Z
in which X, Y and Z each is a halogen or --OR, R being an alkylsulfonyl having 1 to 6 carbon atoms in the alkyl or an arylsulfonyl in which the aryl is phenyl or a phenyl substituted by methyl, methoxy, nitro or a halogen, with ammonia.
2. A process for preparing a compound of 3-aminopyrrolidine having the formula: ##STR7## in which R1 is an alkyl having 1 to 20 carbon atoms, phenyl, an aralkyl having 1 or 2 carbon atoms in the alkylene and 1 or 2 phenyls in the aryl or --CHR2 R3, R2 being phenyl or a phenyl substituted by methyl, methoxy, a halogen or nitro, R3 being hydrogen, an alkyl or phenyl, which comprises reacting 1,2,4-trisubstituted butane having the formula:
XCH.sub.2 CHYCH.sub.2 CH.sub.2 Z
in which X, Y and Z each is a halogen or --OR, R being an alkysulfonyl having 1 to 6 carbon atoms in the alkyl or an arylsulfonyl in which the aryl is phenyl or a phenyl substituted by methyl, methoxy, nitro and a halogen with a primary amine having the formula:
R.sup.1 NH.sub.2
in which R1 is as defined above.
3. A process as claimed in claim 2, in which R1 is benzyl.
4. A process as claimed in claim 2, in which R1 is --CHR2 R3, R2 being phenyl, R3 being hydrogen, methyl or phenyl.
5. A process for preparing 3-aminopyrrolidine comprising catalytically hydrogenating a compound of 3-aminopyrrolidine having the formula: ##STR8## in which R1 is an alkyl having 1 to 20 carbon atoms, phenyl, an aralkyl having 1 or 2 carbon atoms in the alkylene and 1 or 2 phenyls in the aryl or --CHR2 R3, R2 being phenyl or a phenyl substituted by methyl, methoxy, a halogen or nitro, R3 being hydrogen, an alkyl or phenyl or, salts of the compound, with a protonic acid.
US06916936 1985-10-11 1986-10-07 3-aminopyrrolidine compound and process for preparation thereof Expired - Lifetime US4785119A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP22604285A JPH0312055B2 (en) 1985-10-11 1985-10-11
JP22604185A JPH0312054B2 (en) 1985-10-11 1985-10-11
JP60-226042 1985-10-11
JP60-226041 1985-10-11
JP18660786A JPH0320391B2 (en) 1986-08-08 1986-08-08
JP61-186607 1986-08-08

Publications (1)

Publication Number Publication Date
US4785119A true US4785119A (en) 1988-11-15

Family

ID=27325774

Family Applications (1)

Application Number Title Priority Date Filing Date
US06916936 Expired - Lifetime US4785119A (en) 1985-10-11 1986-10-07 3-aminopyrrolidine compound and process for preparation thereof

Country Status (3)

Country Link
US (1) US4785119A (en)
EP (1) EP0218249B1 (en)
DE (2) DE3686387D1 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916152A (en) * 1987-05-01 1990-04-10 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives as antiasthmatics
US4956475A (en) * 1988-03-11 1990-09-11 Abbott Laboratories Preparationof enantiomerically pure 3-protected amino-pyrrolidines
US5099032A (en) * 1988-03-11 1992-03-24 Abbott Laboratories Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids.
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5177217A (en) * 1992-04-27 1993-01-05 Warner-Lambert Company Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
US5264453A (en) * 1988-10-31 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5332817A (en) * 1990-01-04 1994-07-26 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles
US5359088A (en) * 1988-03-11 1994-10-25 Abbott Laboratories Enantiomerically pure aminopyrrolidine compounds
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
US20050165065A1 (en) * 2004-01-22 2005-07-28 Hassan Pajouhesh N-type calcium channel blockers
US20060252751A1 (en) * 2002-11-27 2006-11-09 Chu-Biao Xue 3-Aminopyrrolidine derivaties as modulators of chemokine receptors
CN1331852C (en) * 2005-08-25 2007-08-15 浙江大学 Synthesis method of N-substituted-3-amidopyrrolidine and its bihydrochlorate
US20070225296A1 (en) * 2004-05-28 2007-09-27 Hiroshi Miyazaki Arylalkylamine Compound and Process for Preparing the Same
US20070280943A1 (en) * 2006-06-05 2007-12-06 Friedman Steven M Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
US20080300266A1 (en) * 2004-10-18 2008-12-04 Eli Lilly And Company 1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 Antagonists
US20090326246A1 (en) * 2006-07-28 2009-12-31 Kaneka Corporation Method for Production of Optically Active 3-Amino-Nitrogenated Compound

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1054980A (en) * 1990-02-19 1991-10-02 杏林制药株式会社 Optically active 8-methoxyquinolonecarboxylic acid derivatives, their preparative processes and their intermediates
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
EP1138672A1 (en) * 1998-01-12 2001-10-04 Basilea Pharmaceutica AG Process for the preparation of 3-amino-pyrrolidine derivatives
US6531594B2 (en) * 2000-08-24 2003-03-11 Mitsubishi Chemical Corporation Process for producing 1H-3-aminopyrrolidine and derivatives thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3424762A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H Certain 3-ureidopyrrolidines
US3424760A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3433801A (en) * 1966-03-22 1969-03-18 Robins Co Inc A H 1-aryl-3-(n-lower alkyl amino) pyrrolidines
US3433802A (en) * 1968-06-25 1969-03-18 Robins Co Inc A H 3-(n-lower-alkylanilino)pyrrolidines
US3509171A (en) * 1967-09-14 1970-04-28 Robins Co Inc A H 3-amino-1-carbamyl and thiocarbamyl pyrrolidines
US3549658A (en) * 1968-08-12 1970-12-22 Robins Co Inc A H 1-(1-substituted-3-pyrrolidinyl)-3-arylsulfonylureas
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
US4056535A (en) * 1975-07-09 1977-11-01 Stanford Research Institute N-substituted 3-aminopyrrolidines
FR2500833A1 (en) * 1981-02-27 1982-09-03 Bellon Labor Sa Roger New derivatives of the acid (1-pyrrolidinyl) -7-fluoro-1,4-dihydro-6-oxo-4-naphthyridine 1, 8 3-carboxylic acid and their use as medicament

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3424762A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H Certain 3-ureidopyrrolidines
US3424760A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3433801A (en) * 1966-03-22 1969-03-18 Robins Co Inc A H 1-aryl-3-(n-lower alkyl amino) pyrrolidines
US3509171A (en) * 1967-09-14 1970-04-28 Robins Co Inc A H 3-amino-1-carbamyl and thiocarbamyl pyrrolidines
US3433802A (en) * 1968-06-25 1969-03-18 Robins Co Inc A H 3-(n-lower-alkylanilino)pyrrolidines
US3549658A (en) * 1968-08-12 1970-12-22 Robins Co Inc A H 1-(1-substituted-3-pyrrolidinyl)-3-arylsulfonylureas
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
US4056535A (en) * 1975-07-09 1977-11-01 Stanford Research Institute N-substituted 3-aminopyrrolidines
FR2500833A1 (en) * 1981-02-27 1982-09-03 Bellon Labor Sa Roger New derivatives of the acid (1-pyrrolidinyl) -7-fluoro-1,4-dihydro-6-oxo-4-naphthyridine 1, 8 3-carboxylic acid and their use as medicament

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916152A (en) * 1987-05-01 1990-04-10 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives as antiasthmatics
US4956475A (en) * 1988-03-11 1990-09-11 Abbott Laboratories Preparationof enantiomerically pure 3-protected amino-pyrrolidines
US5099032A (en) * 1988-03-11 1992-03-24 Abbott Laboratories Process for the preparation of enantiomerically homogeneous aminopyrrolidinyl naphthyridine and quinolone carboxylic acids.
US5359088A (en) * 1988-03-11 1994-10-25 Abbott Laboratories Enantiomerically pure aminopyrrolidine compounds
US5264453A (en) * 1988-10-31 1993-11-23 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5514701A (en) * 1988-10-31 1996-05-07 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
US5332817A (en) * 1990-01-04 1994-07-26 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles
US5232929A (en) * 1990-11-28 1993-08-03 Pfizer Inc. 3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
US5177217A (en) * 1992-04-27 1993-01-05 Warner-Lambert Company Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
US5977381A (en) * 1998-01-12 1999-11-02 Hoffmann-La Roche Inc. Process for making 3-amino-pyrolidine derivatives
US20090247474A1 (en) * 2002-11-27 2009-10-01 Chu-Biao Xue 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors
US20060252751A1 (en) * 2002-11-27 2006-11-09 Chu-Biao Xue 3-Aminopyrrolidine derivaties as modulators of chemokine receptors
US8729063B2 (en) 2002-11-27 2014-05-20 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
US8362003B2 (en) 2002-11-27 2013-01-29 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
US7985730B2 (en) 2002-11-27 2011-07-26 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
US7834021B2 (en) 2002-11-27 2010-11-16 Incyte Corporation 3-aminopyrrolidine derivatives as modulators of chemokine receptors
US20050165065A1 (en) * 2004-01-22 2005-07-28 Hassan Pajouhesh N-type calcium channel blockers
US7507760B2 (en) 2004-01-22 2009-03-24 Neuromed Pharmaceuticals Ltd. N-type calcium channel blockers
US8778628B2 (en) 2004-05-28 2014-07-15 Mitsubishi Tanabe Pharma Corporation Arylalkylamine compound and process for preparing the same
US20100249049A1 (en) * 2004-05-28 2010-09-30 Hiroshi Miyazaki Arylalkylamine compound and process for preparing the same
US8703721B2 (en) 2004-05-28 2014-04-22 Mitsubishi Tanabe Pharma Corporation Arylalkylamine compound and process for preparing the same
US8492111B2 (en) 2004-05-28 2013-07-23 Mitsubishi Tanabe Pharma Corporation Arylalkylamine compound and process for preparing the same
US20070225296A1 (en) * 2004-05-28 2007-09-27 Hiroshi Miyazaki Arylalkylamine Compound and Process for Preparing the Same
US8362274B2 (en) 2004-05-28 2013-01-29 Mitsubishi Tanabe Pharma Corporation Arylalkylamine compound and process for preparing the same
US20110218160A1 (en) * 2004-05-28 2011-09-08 Hiroshi Miyazaki Arylalkylamine compound and process for preparing the same
US8759387B2 (en) 2004-05-28 2014-06-24 Mitsubishi Tanabe Pharma Corporation Arylalkylamine compound and process for preparing the same
US7868014B2 (en) 2004-10-18 2011-01-11 Eli Lilly And Company 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists
US20080300266A1 (en) * 2004-10-18 2008-12-04 Eli Lilly And Company 1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 Antagonists
CN1331852C (en) * 2005-08-25 2007-08-15 浙江大学 Synthesis method of N-substituted-3-amidopyrrolidine and its bihydrochlorate
US20070280943A1 (en) * 2006-06-05 2007-12-06 Friedman Steven M Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
US7910108B2 (en) 2006-06-05 2011-03-22 Incyte Corporation Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases
US8030501B2 (en) 2006-07-28 2011-10-04 Kaneka Corporation Process for producing optically active 3-amino nitrogen-containing compounds
US20090326246A1 (en) * 2006-07-28 2009-12-31 Kaneka Corporation Method for Production of Optically Active 3-Amino-Nitrogenated Compound

Also Published As

Publication number Publication date Type
DE3686387T2 (en) 1993-01-14 grant
EP0218249A3 (en) 1989-03-15 application
EP0218249B1 (en) 1992-08-12 grant
DE3686387D1 (en) 1992-09-17 grant
EP0218249A2 (en) 1987-04-15 application

Similar Documents

Publication Publication Date Title
US4973750A (en) Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4582918A (en) Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US5298657A (en) Preparation of substituted guanidines
US6046337A (en) Process for the preparation of a dihydropyridine derivative
US4315007A (en) 4-Amino-6,7-dimethoxyquinazol-2-yl alkylenediamines
US5705640A (en) O-carbamoyl-(d)-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
US4537960A (en) Preparation of carbamates
US4895943A (en) Preparation of 1,4-diazabicyclo(3.2.2)nonane
WO1997048684A1 (en) Preparation of fungicidal quinazolinones and useful intermediates
WO2003016287A2 (en) Process for preparing 1-(carboxymethyl)- and 1-(aminocarbonyl)- pyrimidin-4-one derivatives
Kumamoto et al. Sulfenylation of active methylene compounds with sulfenamides
US6329536B1 (en) Stereoselective process for producing nitro compounds
EP0369691B1 (en) Process for preparing optically active 3-hydroxybutanoic acid
US4140853A (en) Process for the preparation of aminopyridines
EP0001500A1 (en) 1-Carbocyclic aryl-2-mono or -bis(alkoxycarbonyl) guanidino ethanes, and methods for their preparation and the preparation therefrom of 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyclic aryl imidazoles
US5521317A (en) Processes for the preparation of pesticides and intermediates
WO2001036383A1 (en) Process for the preparation of sulfamides
US4018824A (en) 1-Aryloxy-3-aminopropane derivatives
US4656291A (en) Process for producing amidine sulfonic acids
Poindexter et al. The use of 2-oxazolidinones as latent aziridine equivalents. 2. Aminoethylation of aromatic amines, phenols, and thiophenols
US3132151A (en) Specific substituted iminopyrrolidines
US5101044A (en) Preparation of n-substituted pyrrolidin-2-ones
US5648484A (en) Catalytic enantioselective synthesis of a spriofused azetidinone
US5101040A (en) Process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide
US4258187A (en) Process for preparing quinazolinone oxides

Legal Events

Date Code Title Description
AS Assignment

Owner name: TOKYO KASEI KOGYO CO., LTD., 15-9, TOSHIMA 6-CHOME

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:HOJO, KOU;SAKAMOTO, ANJI;TSUTSUMI, MASUMI;AND OTHERS;REEL/FRAME:004616/0001;SIGNING DATES FROM 19860909 TO 19860917

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12